Late-onset phenotype associated with a homozygous GJC2 missense mutation in a Turkish family.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
09 2019
Historique:
received: 21 05 2019
revised: 24 07 2019
accepted: 30 07 2019
pubmed: 23 8 2019
medline: 5 8 2020
entrez: 22 8 2019
Statut: ppublish

Résumé

Recessive mutations in the Gap Junction Protein Gamma 2 (GJC2) gene cause Pelizaeus-Merzbacher-like disease type 1, a severe infantile-onset hypomyelinating leukodystrophy. Milder, late-onset phenotypes including complicated spastic paraplegia in one family (SPG44), and mild tremor in one case, were reported associated to GJC2 homozygous missense mutations. Here, we report a new family with two siblings carrying a different homozygous GJC2 mutation, presenting with late-onset ataxic and pyramidal disturbances, and parkinsonism in one of them. Two affected siblings were studied by neurological examination and brain MRI. Genetic analyses included genome-wide homozygosity mapping in both siblings, and whole exome sequencing in one sib. The resulting candidate gene variant was validated by Sanger sequencing. The affected siblings share a novel homozygous GJC2 missense mutation (c.820G>C, p.Val274Leu), predicted as pathogenic by all used in-silico tools. Brain MRI showed hyperintense signal in T2-weighted images in the internal capsule and subcortical and periventricular white matter, consistent with hypomyelination. Our findings confirm and further expand the late-onset phenotypes of GJC2 mutations, to include prominent ataxia, pyramidal disturbances and mild parkinsonism, and confirm the distinctive associated MRI pattern.

Identifiants

pubmed: 31431325
pii: S1353-8020(19)30353-0
doi: 10.1016/j.parkreldis.2019.07.033
pii:
doi:

Substances chimiques

Connexins 0
connexin 47 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

228-231

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Demy J S Kuipers (DJS)

Erasmus MC, University Medical Center, Rotterdam, the Netherlands, Department of Clinical Genetics.

Zeynep Tufekcioglu (Z)

Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Başar Bilgiç (B)

Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Simone Olgiati (S)

Erasmus MC, University Medical Center, Rotterdam, the Netherlands, Department of Clinical Genetics.

Marjolein H G Dremmen (MHG)

Erasmus MC, University Medical Center, Rotterdam, the Netherlands, Department of Radiology.

Wilfred F J van IJcken (WFJ)

Erasmus MC, University Medical Center, Rotterdam, the Netherlands, Center for Biomics.

Guido J Breedveld (GJ)

Erasmus MC, University Medical Center, Rotterdam, the Netherlands, Department of Clinical Genetics.

Grazia M S Mancini (GMS)

Erasmus MC, University Medical Center, Rotterdam, the Netherlands, Department of Clinical Genetics.

Haşmet A Hanagasi (HA)

Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Murat Emre (M)

Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Vincenzo Bonifati (V)

Erasmus MC, University Medical Center, Rotterdam, the Netherlands, Department of Clinical Genetics. Electronic address: v.bonifati@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH